Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4844050

COc1cc(-c2nc3cc(Br)cnc3[nH]2)ccc1OCc1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 2/20 0.53
PDE4B Q07343 2/20 0.53
PDE4C Q08493 2/20 0.53
PDE4D Q08499 2/20 0.53
CDK4 P11802 1/20 0.44
CCND1 P24385 1/20 0.44
MPO P05164 1/20 0.44
AMY1A P0DUB6 1/20 0.43
HDAC1 Q13547 4/20 0.43
HDAC8 Q9BY41 4/20 0.43
PRMT5 O14744 1/20 0.43
GUSB P08236 1/20 0.42
MGAM O43451 1/20 0.42
APP P05067 2/20 0.41
NPC1 O15118 1/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
SRD5A1 P18405 1/20 0.41
SRD5A2 P31213 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4843458 0.80 PDE5A (0.43) AMY1AGUSBHDAC6
Trifluoroacetic Acid SCHEMBL4842876 0.80 CHEK2 (0.45) GUSBNPC1RAB9ASMN1; SMN2
Trifluoroacetic Acid SCHEMBL5262965 0.80 PIN1 (0.51) HDAC6
Trifluoroacetic Acid SCHEMBL4844143 0.79 ABL1 (0.49) HDAC1HDAC6
Trifluoroacetic Acid SCHEMBL4844163 0.77 HIF1A (0.46)
Trifluoroacetic Acid SCHEMBL4840500 0.77 BRD4 (0.42) HDAC1HDAC8SMN1; SMN2HDAC6
Trifluoroacetic Acid SCHEMBL4835068 0.76 DGAT1 (0.46) HDAC1HPGDSMN1; SMN2HDAC6
Trifluoroacetic Acid SCHEMBL4842803 0.76 KMT2A (0.45) HDAC1HDAC8HDAC6
Trifluoroacetic Acid SCHEMBL4846055 0.76 HPSE (0.44) NPC1RAB9A
SCHEMBL710163 0.76 PDGFRB (0.47) PDE4APDE4BPDE4CPDE4DAMY1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7410966-B2 Use of and some novel imidazopyridines ASTRAZENECA AB (SE) 2008-08-12 US disclosed
EP-1539759-B1 NOVEL IMIDAZOPYRIDINES AND THEIR USE ASTRAZENECA AB (SE) 2007-08-15 EP disclosed
US-20050261333-A1 Use of and some novel imidazopyridines ASTRAZENECA A B (SE) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261333-A1 Use of and some novel imidazopyridines ITK, CSNK1A1, RPS6KA1 PDE4A 598/4885PDE4B 843/4885PDE4C 909/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.